New study finds brain tumors can arise from neurons

October 19, 2012 by Lin Edwards report
A mouse brain contains a glioma (green) three weeks after being injected with a virus that targeted mature astrocytes and altered the expression levels of two oncogenes, HRasV12 and p53. GFAP expression (red) reveals reactive astrocytes surrounding the tumor. Credit: Dr. Eric Bushong

(Medical Xpress)—Researchers from the US and Japan have shown that an aggressive type of brain tumor can arise from normal cells in the central nervous system such as neurons. The cells revert to an earlier, undifferentiated stem cell stage, which can then reproduce prolifically.

The international team of scientists, led by Professor Inder Verma and geneticist Dr Dinorah Friedmann Morvinski, both of the Salk Institute for Biological Studies at La Jolla in California, studied the development of malignant glioblastoma tumors in mice. They had earlier developed a new method of researching cancer by using viruses to introduce cancer-causing genes (oncogenes) into the mice brains, as reported in Phys.Org.

Many of the mouse studies on cancer revolve around transplanting human tissue or cancer cells into immune-compromised mice to begin the process of , but this is not the way that real tumors develop in humans. The San Diego team therefore designed a new method, which aimed to imitate the appearance of by transferring novel oncogenes to healthy via genetically modified viruses.

In the new study, they also introduced oncogenes via viruses, and when tumors began to form they then transferred some of the cells to the brains of healthy mice. They discovered that only as few as 10 cells were needed to produce a tumor in the healthy brain.

Aggressive brain tumors can originate from a range of nervous system cells
The blue, green, red and yellow in this image indicate that these neurons are producing proteins typical of immature nerve cells, evidence that they have reverted to a stem cell-like state. Salk scientists found that mature cortical neurons are capable of reverting to this immature state and developing into an aggressive type of brain tumor that was previously thought to only develop from neural stem cells or glia, another type of cell in the brain. Credit: Dinorah Friedmann-Morvinski

Scientists had earlier assumed glioblastoma tumors only arose from , which support and protect the neurons and supply them with nutrients and oxygen. When stem cells were discovered within the brain, they were also implicated as being capable of leading to .

The new research shows that tumors can in fact have their origins in several types of differentiated cells in the , including , astrocytes (a sub-type of glial cell) and even neurons, when cancer-causing genes are introduced. Neurons do not divide, but when the genes were introduced they were found to transform into stem cells that could reproduce rapidly.

Tumors arising from astrocytes and neurons were similar to the most common and aggressive glioblastoma multiforme (GBM) found in humans. The average length of survival after diagnosis of this type of tumor is around 14 months.

The research, reported in the journal Science, could explain why GBM tumors are so aggressive and difficult to treat, and why they can re-grow even after the tumor has been surgically removed or killed by chemotherapy drugs. In effect every cell left behind after the treatment can start the tumor-building process again.

The next phase of the research will be to learn more about the dedifferentiation process in which cells turn into reproducing stem cells, and then work out a way to block it.

Explore further: How brain tumors invade

More information: Dedifferentiation of Neurons and Astrocytes by Oncogenes Can Induce Gliomas in Mice, Science, DOI: 10.1126/science.1226929

ABSTRACT
Glioblastoma multiforme (GBM) is the most common and aggressive malignant primary brain tumor in humans. Here, we show that gliomas can originate from differentiated cells in the central nervous system (CNS), including cortical neurons. Transduction by oncogenic lentiviral vectors of neural stem cells (NSCs), astrocytes, or even mature neurons in the brain of mice can give rise to malignant gliomas. All the tumors, irrespective of the site of injection (initiating population), share common features of high expression of stem or progenitor markers and low expression of differentiation markers. Microarray analysis revealed that tumors of astrocytic and neuronal origin match the mesenchymal GBM subtype. We propose that most differentiated cells in the CNS upon defined genetic alterations undergo dedifferentiation to generate a NSC or progenitor state to initiate and maintain the tumor progression, as well as to give rise to the heterogeneous populations observed in malignant gliomas.

Related Stories

How brain tumors invade

December 12, 2011
Scientists have pinpointed a protein that allows brains tumors to invade healthy brain tissue, according to work published this week in the Journal of Experimental Medicine.

Study suggests new treatment target for glioblastoma multiforme

August 1, 2012
A study by UT Southwestern Medical Center researchers published online today in Nature reveals new insight into why the most common, deadly kind of brain tumor in adults recurs and identifies a potential target for future ...

Recommended for you

Bolstering fat cells offers potential new leukemia treatment

October 16, 2017
Killing cancer cells indirectly by powering up fat cells in the bone marrow could help acute myeloid leukemia patients, according to a new study from McMaster University.

Study reveals complex biology, gender differences, in kidney cancer

October 13, 2017
A new study is believed to be the first to describe the unique role of androgens in kidney cancer, and it suggests that a new approach to treatment, targeting the androgen receptor (AR), is worth further investigation.

Cholesterol byproduct hijacks immune cells, lets breast cancer spread

October 12, 2017
High cholesterol levels have been associated with breast cancer spreading to other sites in the body, but doctors and researchers don't know the cause for the link. A new study by University of Illinois researchers found ...

New drug hope for rare bone cancer patients

October 12, 2017
Patients with a rare bone cancer of the skull and spine - chordoma - could be helped by existing drugs, suggest scientists from the Wellcome Trust Sanger Institute, University College London Cancer Institute and the Royal ...

Scientists pinpoint surprising origin of melanoma

October 12, 2017
Led by Jean-Christophe Marine (VIB-KU Leuven), a team of researchers has tracked down the cellular origin of cutaneous melanoma, the deadliest form of skin cancer. The team was surprised to observe that these very aggressive ...

Team finds a potentially better way to treat liver cancer

October 12, 2017
A Keck School of Medicine of USC research team has identified how cancer stem cells survive. This finding may one day lead to new therapies for liver cancer, one of the few cancers in the United States with an incidence rate ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

sgt_doom
not rated yet Oct 19, 2012
This makes tremendous sense when compared with Roger Penrose's prediction years ago, pertaining to the difficulty AI researchers would run into because they were thinking of the neuron as the smallest component, instead of yet another network within the cortical networks.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.